APP and Alzheimer disease: A decrease in SDF-1α expression is related to the excessive production of APP in transgenic mice, contributing to cognitive defects, while SDF-1α pretreatment in AD mice model was found to reduce neuronal dendritic degeneration and neuronal apoptosis (Raman et al., 2011).